Middle East

Middle East Pharmaceutical Industries Company, widely known as SPIMACO, is a leading Saudi Arabian pharmaceutical company engaged in the development, manufacturing, and marketing of a broad range of pharmaceutical products and medical appliances. The company operates a large-scale manufacturing facility in Al-Qassim and produces various dosage forms, including tablets, capsules, liquids, and injectables, covering therapeutic areas such as anti-infectives, diabetes, and cardiovascular health. SPIMACO serves as a critical player in the MENA region's healthcare sector through both its proprietary generic portfolio and extensive contract manufacturing partnerships with global pharmaceutical giants. The company is publicly traded on the Saudi Exchange (Tadawul) and continues to expand its footprint through strategic investments in biotechnology and specialized therapeutics.